Karnataka approves cleft care mentorship programme in State-run hospitals
Cleft lip and cleft palate are among the most common congenital anomalies affecting children in Karnataka. Surgical correction is essential for the physical, psychological, and social rehabilitation of affected individuals. However, there exists a gap in the availability of adequately trained maxillofacial surgeons in government hospitals, particularly in rural and underserved regions.
At present, most of the cleft lip and cleft palate cases identified by the Rashtriya Bal Swasthya Karyakram (RBSK) team or District Early Intervention Centre (DEIC) are referred to empanelled private health facilities and NGOs for corrective surgery. Besides, only around 20 procedures have been conducted under the Ayushman Bharat Arogya Karnataka (AB-ArK) scheme over the last five years by one government medical college, four private medical colleges and two private hospitals.
According to a government order issued on July 28, a gap analysis of government hospitals will be done by Suvarna Arogya Suraksha Trust (SAST), the nodal agency implementing the State's health schemes, to identify and provide the required infrastructure. equipment or HR for conducting cleft lip and cleft palate corrective surgeries.
'A pool of mentor surgeons should be prepared, based on qualifying criteria, as decided by a committee of technical experts. A probable list of maxillofacial surgeons working in the Health and Medical Education departments should be prepared. Children who require corrective surgery should be identified by RBSK teams and allocated to private hospitals, NGOs and government hospitals for surgery. The mentor surgeons should conduct the surgery at government hospitals, and also train other surgeons,' the GO states.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
3 days ago
- New Indian Express
Hassan, Mandya Top Gainers under AB-PMJAY in Karnataka
MANGALURU: Hassan, Mandya and Belagavi have emerged as top gainers in healthcare delivery under the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) in Karnataka. Hassan has recorded 10,65,825 hospital admissions since the scheme's inception in 2018. The district's performance accelerated rapidly in recent years, with 3.65 lakh admissions in 2024-25 alone, making it the single highest contributor to AB-PMJAY in Karnataka. Close behind is Mandya, with 9,86,883 cumulative admissions, including an impressive 3.07 lakh in 2023-24 and 2.98 lakh in 2024-25, solidifying its place among the top beneficiaries. Belagavi, with 6,34,513 admissions, has shown steady year-on-year growth, expanding from just over 6,000 admissions in 2018-19 to more than 2.06 lakh in the latest year. Mysuru, a consistent performer, has logged 6,13,065 total admissions, supported by robust infrastructure and awareness, while Tumakuru rounds out the top five with 5,07,315 admissions, reflecting strong gains especially after 2022. These five districts together account for more than 38 lakh hospitalisations, demonstrating the effectiveness of decentralised implementation, improved public awareness, and increased hospital empanelment across the state.
New Indian Express
4 days ago
- New Indian Express
Work on Jeypore economic corridor to start soon: CM Majhi
BHUBANESWAR/ JEYPORE: Chief Minister Mohan Charan Majhi on Sunday announced that construction of the six-lane Bhubaneswar-Berhampur-Jeypore economic corridor will be started soon. On the second day of his visit to Koraput district, Majhi also inaugurated the 650-bed hospital at Saheed Laxman Naik Medical College built at a cost of Rs 280 crore. Addressing a function on the occasion, the chief minister said the economic corridor will play a vital role in all-round development of Koraput district by boosting connectivity to different parts of the state. The expansion of the hospital of the medical college will be a boon for the people of the district and neighbouring region as they will no longer have to travel to other cities for availing quality treatment and health services. The new hospital will benefit the people of Koraput, Malkangiri, Nabarangpur, Rayagada and also the neighbouring areas of Andhra Pradesh and Chhattisgarh, he said. Announcing that all vacancies in medical and allied posts at the SLN MCH will be filled up soon, Majhi said a cancer hospital is also being built on an area of two acre adjacent to the hospital at a cost Rs 41.15 crore. Emphasising focus of his government to provide best of healthcare in every district, the CM said there are 12 government medical colleges in the state at present and four more are coming up in Dhenkanal, Jagatsinghpur, Bhadrak and Nabarangpur districts. He also said the implementation of Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY) has greatly benefitted the people of the state with more than 3.46 crore covered under the scheme along with Gopabandhu Jan Arogya Yojana (GJAY). The government has already released Rs 900 crore in lieu of cashless treatment provided to the people in best of hospitals, he said. Under the Ayushman Vay Vandana Yojana, 8,644 senior citizens aged above 70 have received free treatment worth Rs 35.60 crore. In Koraput district alone, over three lakh AB-PMJAY and GJAY cards have been distributed, with 9,006 people enrolled under the senior citizens' scheme, he added. The chief minister said four private hospitals in Koraput district are empanelled under the ABPMJAY-GJAY, enabling local access to cashless treatment. Health and Family Welfare minister Mukesh Mahaling was present among others.
Economic Times
4 days ago
- Economic Times
China's Ab&B Bio-Tech shares soar 170% driven by retail demand
Shares of China's Ab&B Bio-Tech gained nearly 170% on Monday, as the vaccine development firm debuted on the Hong Kong Stock Exchange after it raised $55 million in an initial public offering. ADVERTISEMENT The retail tranche of the IPO was nearly 4,000 times oversubscribed by investors, the company's filings showed. The share hit a high of HK$34.80 in early trade, with about 7.68 million Ab&B Bio-Tech shares worth HK$253.8 million ($32.33 million) changing hands on the Hong Kong Stock Exchange. The Hang Seng Index was up 0.2% on Monday. Ab&B Bio-Tech, which is developing influenza and rabies vaccines, sold 33.44 million shares at HK$12.90 each, according to the filings. The price set was at the bottom of the range flagged to investors when the deal was launched. The strong demand from Hong Kong's retail investors meant 651,600 shares due to be sold to institutional investors were re-allocated to those public investors, the filings showed. ADVERTISEMENT There were nearly 192,000 applications from retail investors to buy stock and 18,984 of those were allocated shares. Despite the retail buying, weak demand from institutions meant the institutional portion of the deal was only just covered. ADVERTISEMENT ($1 = 7.8498 Hong Kong dollars). (You can now subscribe to our ETMarkets WhatsApp channel)
